An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Pifeltro

Chemical Namedoravirine
Dosage FormTablet (oral; 100 mg)
Drug ClassAntivirals
SystemBlood
CompanyMerck & Co.
Approval Year2018

Indication

  • To treat HIV-1 infection in conjunction with other antiretroviral agents in adults with no previous antiretroviral treatment history.
Last updated on 10/30/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Pifeltro (Doravirine) Prescribing Information2018Merck & Co., Inc., Whitehouse Station, NJ
Document TitleYearSource
Clinical Review Report: Doravirine (Pifeltro): (Merck Canada Inc.). 2019CADTH
Document TitleYearSource
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0. 2020HIV Medicine